https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-722011-11-23 00:00:002019-02-15 08:46:36Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-792011-11-16 00:00:002019-02-15 08:45:53Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-442011-11-07 00:00:002019-02-15 08:46:33Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-422011-11-02 00:00:002019-02-15 08:40:01Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-40052011-11-01 00:00:002019-02-15 08:46:01Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-22 / Cancer Immunol. Immunother. 2012 May;61(5):629-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-22 / Cancer Immunol. Immunother. 2012 May;61(5):629-412011-10-22 00:00:002019-02-15 08:52:17Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-20 / J Transl Med 2011 Oct;9:178
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-20 / J Transl Med 2011 Oct;9:1782011-10-20 00:00:002019-02-15 08:50:33Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-18 / Int. Immunopharmacol. 2011 Dec;11(12):2200-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-18 / Int. Immunopharmacol. 2011 Dec;11(12):2200-72011-10-18 00:00:002019-02-15 08:47:45Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-15 / Immunopharmacol Immunotoxicol 2012 Jun;34(3):465-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-15 / Immunopharmacol Immunotoxicol 2012 Jun;34(3):465-92011-10-15 00:00:002019-02-15 08:46:01Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-10-03 / Eur. Urol. 2012 Feb;61(2):290-306
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-10-03 / Eur. Urol. 2012 Feb;61(2):290-3062011-10-03 00:00:002019-02-15 08:52:46Current vaccination strategies for prostate cancer
